« Previous
Next »
Subjects
- Adalimumab -- therapeutic use1
- Benchmarking1
- Comparative Effectiveness Research1
- Etanercept -- therapeutic use1
- Humans1
- Immunologic Factors -- adverse effects1
- Immunologic Factors -- economics1
- Immunologic Factors -- therapeutic use1
- Interleukin-12 -- antagonists & inhibitors1
- Interleukin-171
- Interleukin-23 -- antagonists & inhibitors1
- Phosphodiesterase 4 Inhibitors1
- Phototherapy1
- Psoriasis -- drug therapy1
- Psoriasis -- immunology[remove]1
- Psoriasis -- therapy1
- Randomized Controlled Trials as Topic1
- Severity of Illness Index1
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors1
- United States1